Global Infectious Disease Molecular Diagnostics Market Size Study, By Product (Instruments, Reagents), By Technology (Mass Spectrometry, PCR, In Situ Hybridization), By Application, By End-Use, and Regional Forecasts 2022-2032

March 2025 | 285 pages | ID: G075FCF8572AEN
Bizwit Research & Consulting LLP

Abstracts

The Global Infectious Disease Molecular Diagnostics Market is valued at approximately USD 52 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 3.9% over the forecast period 2024-2032. The increasing prevalence of infectious diseases worldwide, coupled with advancements in molecular diagnostic technologies, is propelling market growth. The growing demand for rapid and accurate disease detection methods, particularly in the wake of emerging infectious threats, has fueled investments in next-generation sequencing (NGS), polymerase chain reaction (PCR), and CRISPR-based diagnostic platforms. Additionally, technological innovations have significantly improved the precision, speed, and accessibility of diagnostic tests, enabling healthcare providers to make data-driven treatment decisions.

The rising incidence of diseases such as tuberculosis, hepatitis, sexually transmitted infections (STIs), respiratory illnesses, and antimicrobial-resistant infections has accelerated the adoption of molecular diagnostics. Government and private sector funding for infectious disease research, clinical trials, and innovative diagnostic tools are further amplifying market expansion. For instance, in January 2025, Rhode Island Hospital secured a USD 1 million grant from CARB-X to develop a direct-from-blood PCR test for pneumonia-causing bacteria. Similarly, Kryptos Biotechnologies received USD 1.2 million in funding to advance its rapid multiplex molecular diagnostic technology for STIs. These initiatives underscore the increasing focus on precision diagnostics to curb infectious disease outbreaks and improve patient outcomes.

Geographically, North America dominated the infectious disease molecular diagnostics market, accounting for a 40.95% revenue share in 2024. The region's strong foothold in diagnostic technologies, robust healthcare infrastructure, and high demand for rapid testing solutions contribute to its market leadership. The Asia-Pacific region is anticipated to witness the fastest CAGR over the forecast period, driven by rising disease prevalence, growing investments in diagnostic infrastructure, and increasing awareness about early disease detection. Countries such as China, India, and Japan are experiencing a surge in demand for molecular diagnostic tests due to their large patient populations, government funding for healthcare innovation, and advancements in home-based and point-of-care (PoC) testing solutions.

The growing adoption of artificial intelligence (AI) and digital health platforms in molecular diagnostics is expected to reshape the market landscape. AI-driven diagnostic tools enhance the accuracy and efficiency of pathogen detection, reducing false positives and improving diagnostic reliability. Additionally, cloud-based diagnostic platforms are streamlining real-time disease surveillance and outbreak management. With continued innovations in diagnostic technologies and increasing collaboration between public and private sector entities, the infectious disease molecular diagnostics market is poised for sustained growth throughout the forecast period.

Major Market Players Included in This Report Are:

• Abbott
• Danaher Corporation
• Bio-Rad Laboratories, Inc.
• bioMйrieux SA
• F. Hoffmann-La Roche Ltd
• Agilent Technologies, Inc.
• Becton, Dickinson and Company
• Hologic, Inc. (Gen-Probe)
• Illumina, Inc.
• Grifols S.A.
• Qiagen
• Siemens Healthineers AG
• Sysmex Corporation
• Thermo Fisher Scientific
• PerkinElmer, Inc.

The Detailed Segments and Sub-Segments of the Market Are Explained Below:

By Product:

• Instruments
• Reagents
• Services

By Technology:

• Polymerase Chain Reaction (PCR)
• Multiplex PCR
• Other PCR
• In Situ Hybridization (ISH)
• Isothermal Nucleic Acid Amplification Technology (INAAT)
• Chips and Microarrays
• Mass Spectrometry
• Transcription Mediated Amplification (TMA)
• Others

By Application:

• Respiratory Diseases
• Tuberculosis
• Meningitis
• Gastrointestinal Tract Infections
• Human Papillomavirus (HPV)
• Sexually Transmitted Infections (STIs)
• Sepsis
• Drug-Resistant Diseases
• Others

By End-Use:

• Hospitals
• Clinics
• Diagnostic Laboratories
• Research Institutes

By Region:

North America:

• U.S.
• Canada
• Mexico

Europe:

• UK
• Germany
• France
• Italy
• Spain
• Denmark
• Sweden
• Norway

Asia-Pacific:

• China
• Japan
• India
• Australia
• South Korea
• Thailand

Latin America:

• Brazil
• Argentina

Middle East & Africa (MEA):

• South Africa
• Saudi Arabia
• UAE
• Kuwait

Years Considered for the Study Are as Follows:

• Historical Year – 2022
• Base Year – 2023
• Forecast Period – 2024 to 2032

Key Takeaways:

• Market Estimates & Forecast for 10 years (2022-2032).
• Annualized revenues and regional-level analysis for each market segment.
• Detailed analysis of the geographical landscape, including country-level insights.
• Competitive landscape featuring company profiles and strategic market positioning.
• Analysis of key business strategies, including mergers, acquisitions, and technological innovations.
• Demand-side and supply-side market analysis to highlight growth opportunities.

Contents

CHAPTER 1. GLOBAL INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKET EXECUTIVE SUMMARY

1.1. Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
  1.3.1. By Product
  1.3.2. By Technology
  1.3.3. By Application
  1.3.4. By End-Use
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion

CHAPTER 2. GLOBAL INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKET DEFINITION AND RESEARCH ASSUMPTIONS

2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
  2.3.1. Inclusion & Exclusion
  2.3.2. Limitations
  2.3.3. Supply Side Analysis
    2.3.3.1. Availability
    2.3.3.2. Infrastructure
    2.3.3.3. Regulatory Environment
    2.3.3.4. Market Competition
    2.3.3.5. Economic Viability (Consumer’s Perspective)
  2.3.4. Demand Side Analysis
    2.3.4.1. Regulatory Frameworks
    2.3.4.2. Technological Advancements
    2.3.4.3. Environmental Considerations
    2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates

CHAPTER 3. GLOBAL INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKET DYNAMICS

3.1. Market Drivers
  3.1.1. Rising Prevalence of Infectious Diseases Worldwide
  3.1.2. Technological Advancements in Molecular Diagnostics
  3.1.3. Growing Adoption of Point-of-Care Testing
3.2. Market Challenges
  3.2.1. High Cost of Molecular Diagnostic Tests
  3.2.2. Regulatory Hurdles and Stringent Approval Processes
3.3. Market Opportunities
  3.3.1. Expansion in Emerging Markets
  3.3.2. Increasing Focus on Personalized Medicine

CHAPTER 4. GLOBAL INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKET INDUSTRY ANALYSIS

4.1. Porter’s Five Force Model
  4.1.1. Bargaining Power of Suppliers
  4.1.2. Bargaining Power of Buyers
  4.1.3. Threat of New Entrants
  4.1.4. Threat of Substitutes
  4.1.5. Competitive Rivalry
  4.1.6. Futuristic Approach to Porter’s Five Force Model
  4.1.7. Porter’s Five Force Impact Analysis
4.2. PESTEL Analysis
  4.2.1. Political Factors
  4.2.2. Economic Factors
  4.2.3. Social Factors
  4.2.4. Technological Factors
  4.2.5. Environmental Factors
  4.2.6. Legal Factors
4.3. Top Investment Opportunities
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion

CHAPTER 5. GLOBAL INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKET SIZE & FORECASTS BY PRODUCT (2022-2032)

5.1. Segment Dashboard
5.2. Market Revenue Trend Analysis (USD Billion)
  5.2.1. Instruments
  5.2.2. Reagents
  5.2.3. Services

CHAPTER 6. GLOBAL INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKET SIZE & FORECASTS BY TECHNOLOGY (2022-2032)

6.1. Segment Dashboard
6.2. Market Revenue Trend Analysis (USD Billion)
  6.2.1. Polymerase Chain Reaction (PCR)
  6.2.2. In Situ Hybridization
  6.2.3. Isothermal Nucleic Acid Amplification Technology (INAAT)
  6.2.4. Chips and Microarrays
  6.2.5. Mass Spectrometry
  6.2.6. Transcription Mediated Amplification
  6.2.7. Others

CHAPTER 7. GLOBAL INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKET SIZE & FORECASTS BY APPLICATION (2022-2032)

7.1. Segment Dashboard
7.2. Market Revenue Trend Analysis (USD Billion)
  7.2.1. Respiratory Diseases
  7.2.2. Tuberculosis
  7.2.3. Meningitis
  7.2.4. Gastrointestinal Tract Infections
  7.2.5. Human Papillomavirus (HPV)
  7.2.6. Sexually Transmitted Infections
  7.2.7. Sepsis
  7.2.8. Drug Resistance Diseases
  7.2.9. Others

CHAPTER 8. GLOBAL INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKET SIZE & FORECASTS BY END-USE (2022-2032)

8.1. Segment Dashboard
8.2. Market Revenue Trend Analysis (USD Billion)
  8.2.1. Hospitals
  8.2.2. Clinics
  8.2.3. Diagnostic Laboratories
  8.2.4. Research Institutes

CHAPTER 9. GLOBAL INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKET SIZE & FORECASTS BY REGION (2022-2032)

9.1. North America
  9.1.1. U.S.
  9.1.2. Canada
  9.1.3. Mexico
9.2. Europe
  9.2.1. UK
  9.2.2. Germany
  9.2.3. France
  9.2.4. Italy
  9.2.5. Spain
  9.2.6. Denmark
  9.2.7. Sweden
  9.2.8. Norway
9.3. Asia-Pacific
  9.3.1. China
  9.3.2. Japan
  9.3.3. India
  9.3.4. Australia
  9.3.5. South Korea
  9.3.6. Thailand
9.4. Latin America
  9.4.1. Brazil
  9.4.2. Argentina
9.5. Middle East & Africa
  9.5.1. South Africa
  9.5.2. Saudi Arabia
  9.5.3. UAE
  9.5.4. Kuwait

CHAPTER 10. COMPETITIVE INTELLIGENCE

10.1. Key Company SWOT Analysis
  10.1.1. Danaher Corporation
  10.1.2. Abbott Laboratories
  10.1.3. Roche Diagnostics
10.2. Top Market Strategies
10.3. Company Profiles
  10.3.1. Abbott
  10.3.2. Danaher Corporation
  10.3.3. Bio-Rad Laboratories, Inc.
  10.3.4. bioMйrieux SA
  10.3.5. F. Hoffmann-La Roche Ltd
  10.3.6. Agilent Technologies, Inc.
  10.3.7. Becton, Dickinson and Company
  10.3.8. Hologic, Inc. (Gen-Probe)
  10.3.9. Illumina, Inc.
  10.3.10. Grifols S.A.
  10.3.11. Qiagen
  10.3.12. Siemens Healthineers AG
  10.3.13. Sysmex Corporation

CHAPTER 11. RESEARCH PROCESS

11.1. Research Process
  11.1.1. Data Mining
  11.1.2. Analysis
  11.1.3. Market Estimation
  11.1.4. Validation
  11.1.5. Publishing
11.2. Research Attributes

List Of Tables

LIST OF TABLES

TABLE 1. Global Infectious Disease Molecular Diagnostics Market, Report Scope
TABLE 2. Global Infectious Disease Molecular Diagnostics Market Estimates & Forecasts by Region (2022-2032) (USD Million/Billion)
TABLE 3. Global Infectious Disease Molecular Diagnostics Market Estimates & Forecasts by Product (2022-2032) (USD Million/Billion)
TABLE 4. Global Infectious Disease Molecular Diagnostics Market Estimates & Forecasts by Technology (2022-2032) (USD Million/Billion)
TABLE 5. Global Infectious Disease Molecular Diagnostics Market Estimates & Forecasts by Application (2022-2032) (USD Million/Billion)
TABLE 6. Global Infectious Disease Molecular Diagnostics Market Estimates & Forecasts by End-Use (2022-2032) (USD Million/Billion)
TABLE 7. North America Infectious Disease Molecular Diagnostics Market, by Country, 2022-2032 (USD Million/Billion)
TABLE 8. Europe Infectious Disease Molecular Diagnostics Market, by Country, 2022-2032 (USD Million/Billion)
TABLE 9. Asia Pacific Infectious Disease Molecular Diagnostics Market, by Country, 2022-2032 (USD Million/Billion)
TABLE 10. Latin America Infectious Disease Molecular Diagnostics Market, by Country, 2022-2032 (USD Million/Billion)
TABLE 11. Middle East & Africa Infectious Disease Molecular Diagnostics Market, by Country, 2022-2032 (USD Million/Billion)
TABLE 12. Global Market Share of Leading Players, 2023 (%)
TABLE 13. Global Infectious Disease Molecular Diagnostics Market: Competitive Benchmarking
TABLE 14. Key Developments in the Market, 2022-2025
TABLE 15. Regulatory Landscape for Infectious Disease Molecular Diagnostics Market by Region
TABLE 16. Market Trends and Growth Opportunities in Infectious Disease Molecular Diagnostics
TABLE 17. Impact of COVID-19 on the Infectious Disease Molecular Diagnostics Market
TABLE 18. Key Funding and Investment Activities in the Market (2022-2025)
TABLE 19. Pricing Analysis of Molecular Diagnostic Tests by Region (2022-2032)
TABLE 20. Key Strategies Adopted by Market Players (2022-2025)
This list is not complete. The final report contains more than 100 tables. The list may be updated in the final deliverable.

List Of Figures

LIST OF FIGURES

FIGURE 1. Global Infectious Disease Molecular Diagnostics Market, Research Methodology
FIGURE 2. Global Infectious Disease Molecular Diagnostics Market, Market Estimation Techniques
FIGURE 3. Global Market Size Estimates & Forecast Methods
FIGURE 4. Key Trends in the Global Infectious Disease Molecular Diagnostics Market, 2023
FIGURE 5. Global Infectious Disease Molecular Diagnostics Market Growth Prospects (2022-2032)
FIGURE 6. Global Infectious Disease Molecular Diagnostics Market, Porter’s Five Forces Model
FIGURE 7. Global Infectious Disease Molecular Diagnostics Market, PESTEL Analysis
FIGURE 8. Global Infectious Disease Molecular Diagnostics Market, Value Chain Analysis
FIGURE 9. Global Infectious Disease Molecular Diagnostics Market, Revenue Share by Product (2023)
FIGURE 10. Global Infectious Disease Molecular Diagnostics Market, Revenue Share by Technology (2023)
FIGURE 11. Global Infectious Disease Molecular Diagnostics Market, Revenue Share by Application (2023)
FIGURE 12. Global Infectious Disease Molecular Diagnostics Market, Revenue Share by End-Use (2023)
FIGURE 13. North America Infectious Disease Molecular Diagnostics Market Revenue Share (2023)
FIGURE 14. Europe Infectious Disease Molecular Diagnostics Market Revenue Share (2023)
FIGURE 15. Asia Pacific Infectious Disease Molecular Diagnostics Market Revenue Share (2023)
FIGURE 16. Latin America Infectious Disease Molecular Diagnostics Market Revenue Share (2023)
FIGURE 17. Middle East & Africa Infectious Disease Molecular Diagnostics Market Revenue Share (2023)
FIGURE 18. Market Share Analysis of Key Players in the Global Infectious Disease Molecular Diagnostics Market (2023)
FIGURE 19. Investments and Funding in Infectious Disease Molecular Diagnostics (2022-2025)
FIGURE 20. Key Strategic Developments in the Infectious Disease Molecular Diagnostics Market (2022-2025)
This list is not complete. The final report contains more than 50 figures. The list may be updated in the final deliverable.